Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | Insights into the treatment of peripheral T-cell lymphomas and the role of autologous transplant

Neha Mehta-Shah • 30 Sep 2022
SOHO 2022
Lymphoma Peripheral T-Cell Lymphoma Rare Diseases T-Cell Lymphoma Anthracycline CHOP

Neha Mehta-Shah, MD, Washington University in St Louis, St Louis, MO, gives an overview of treatment approaches for peripheral T-cell lymphomas (PTCL) and the role of autologous stem cell transplantation (autoSCT) in these patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Neha Mehta-Shah

4:41
ASCO 2023 rare lymphoma highlights: JACKPOT8, IELSG37, and mogamulizumab + CHOP in ATL
Neha Mehta-Shah • 5 Jun 2023
1:54
Navigating regulatory challenges in developing and approving therapies for rare lymphomas
Neha Mehta-Shah • 5 Jun 2023
1:31
Advantages of bispecific antibodies for lymphoma: mosunetuzumab, epcoritamab & glofitamab
Neha Mehta-Shah • 5 Jun 2023
1:41
SWOG S1826: nivolumab+AVD vs brentuximab vedotin+AVD for advanced stage Hodgkin lymphoma
Neha Mehta-Shah • 5 Jun 2023

Related Videos

1:24
Employing CAR-T therapies in earlier lines of large B-cell lymphoma treatment
Paolo Cortesi • 24 Apr 2024
2:45
The value of axi-cel as a second-line treatment in R/R LBCL
Paolo Cortesi • 24 Apr 2024
5:42
Promising therapeutic efficacy of EBV-specific T-cell immunotherapy tabelecleucel in PTLD
Nina Worel • 25 Apr 2024
4:24
Investigating production failure and out-of-specification production of CAR T-cell therapeutics
Nina Worel • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals